{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:18:06Z","timestamp":1790050686531,"version":"4.0.1"},"reference-count":24,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T00:00:00Z","timestamp":1332460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Science"],"published-print":{"date-parts":[[2012,6]]},"abstract":"<jats:p>We conducted a retrospective <jats:styled-content style=\"fixed-case\">J<\/jats:styled-content>apan\u2013<jats:styled-content style=\"fixed-case\">K<\/jats:styled-content>orea multicenter study to better elucidate the clinicopathologic features and therapeutic modalities for aggressive natural killer cell leukemia (<jats:styled-content style=\"fixed-case\">ANKL<\/jats:styled-content>). A total of 34 patients were analyzed. The median age of the patients was 40\u00a0years. Among the patients in the study, four had a history of <jats:styled-content style=\"fixed-case\">E<\/jats:styled-content>pstein\u2013<jats:styled-content style=\"fixed-case\">B<\/jats:styled-content>arr virus\u2010related disorders. Three types of <jats:styled-content style=\"fixed-case\">ANKL<\/jats:styled-content> cells were categorized according to their morphological features. Leukemic cells were below 20% in both peripheral blood and bone marrow of 11 patients. The clinical characteristics and prognoses of these 11 patients did not differ significantly from those of the others. As an initial therapy, <jats:sc>l<\/jats:sc>\u2010asparaginase chemotherapy resulted in a better response. A total of six patients received allogeneic hematopoietic stem cell transplantation (<jats:styled-content style=\"fixed-case\">HSCT<\/jats:styled-content>) and two received autologous <jats:styled-content style=\"fixed-case\">HSCT<\/jats:styled-content>, with all in non\u2010complete remission (<jats:styled-content style=\"fixed-case\">CR<\/jats:styled-content>). After <jats:styled-content style=\"fixed-case\">HSCT<\/jats:styled-content>, four with allogeneic and one with autologous <jats:styled-content style=\"fixed-case\">HSCT<\/jats:styled-content> reached <jats:styled-content style=\"fixed-case\">CR<\/jats:styled-content>. Median survival of all patients was 51\u00a0days. Median survival for the patients with and without <jats:styled-content style=\"fixed-case\">HSCT<\/jats:styled-content> were 266 and 36\u00a0days, respectively. A total of two patients with allogeneic <jats:styled-content style=\"fixed-case\">HSCT<\/jats:styled-content> were alive and in <jats:styled-content style=\"fixed-case\">CR<\/jats:styled-content>. All patients without <jats:styled-content style=\"fixed-case\">HSCT<\/jats:styled-content> died of <jats:styled-content style=\"fixed-case\">ANKL<\/jats:styled-content>. The use of <jats:sc>l<\/jats:sc>\u2010asparaginase was indicated as a factor for longer survival (<jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content> 0.33, 95% confidence interval; 0.13\u20130.83, <jats:italic>P\u00a0<\/jats:italic>=\u00a00.02). Early diagnosis of <jats:styled-content style=\"fixed-case\">ANKL<\/jats:styled-content>,<jats:sc> l<\/jats:sc>\u2010asparaginase\u2010based chemotherapy and allogeneic <jats:styled-content style=\"fixed-case\">HSCT<\/jats:styled-content> might lead to improved patient outcomes. (<jats:italic>Cancer Sci<\/jats:italic> 2012; 103: 1079\u20131083)<\/jats:p>","DOI":"10.1111\/j.1349-7006.2012.02251.x","type":"journal-article","created":{"date-parts":[[2012,2,23]],"date-time":"2012-02-23T18:50:54Z","timestamp":1330023054000},"page":"1079-1083","source":"Crossref","is-referenced-by-count":67,"title":["Aggressive natural killer cell leukemia: Therapeutic potential of <scp>l<\/scp>\u2010asparaginase and allogeneic hematopoietic stem cell transplantation"],"prefix":"10.1111","volume":"103","author":[{"given":"Fumihiro","family":"Ishida","sequence":"first","affiliation":[{"name":"Department of Hematology Shinshu University School of Medicine Matsumoto Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Hyeh","family":"Ko","sequence":"additional","affiliation":[{"name":"Department of Pathology and Samsung Medical Center Seoul Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Seog","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology Samsung Medical Center Seoul Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Suzumiya","sequence":"additional","affiliation":[{"name":"Cancer Center Shimane University Hospital Izumo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Isobe","sequence":"additional","affiliation":[{"name":"Department of Hematology Juntendo University School of Medicine Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Oshimi","sequence":"additional","affiliation":[{"name":"Department of Hematology Juntendo University School of Medicine Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Pathology and Clinical Laboratories Nagoya University Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritsuro","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of HSCT Data Management and Biostatistics Nagoya University Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,3,23]]},"reference":[{"key":"e_1_2_8_2_1","first-page":"276","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoic Tissues","author":"Chan JKC","year":"2008"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1586\/ehm.10.51"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-010-0738-y"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403262"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1532\/IJH97.A10612"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1159\/000193225"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403732"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190400004513"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.20245"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.3"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-06-222794"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-02-271080"},{"key":"e_1_2_8_14_1","first-page":"198","volume-title":"WHO Classification of Tumours: Pathology & Genetics of Tumours of Haematopoietic and Lymphoic Tissues","author":"Chan JKC","year":"2001"},{"key":"e_1_2_8_15_1","volume-title":"WHO Handbook for Reporting Results of Cancer Treatment","author":"World Health Organization","year":"1979"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2008.01090.x"},{"key":"e_1_2_8_17_1","first-page":"1343","article-title":"Aggressive natural killer cell leukemia: clinical features and treatment outcome","volume":"87","author":"Song SY","year":"2002","journal-title":"Haematologica"},{"key":"e_1_2_8_18_1","first-page":"258","article-title":"[Aggressive NK\u2010cell leukemia with sustained relapse\u2010free survival after allogeneic peripheral blood stem cell transplantation]","volume":"51","author":"Ino K","year":"2010","journal-title":"Jan J Clin Hematol [Rinsho Ketsueki]"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2008.00768.x"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2010.284"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.11-3-263"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp418"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05694.x"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.35.6287"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06835.x"}],"container-title":["Cancer Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1349-7006.2012.02251.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1349-7006.2012.02251.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T21:22:27Z","timestamp":1700601747000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1349-7006.2012.02251.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,23]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["10.1111\/j.1349-7006.2012.02251.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1349-7006.2012.02251.x","archive":["Portico"],"relation":{},"ISSN":["1347-9032","1349-7006"],"issn-type":[{"value":"1347-9032","type":"print"},{"value":"1349-7006","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,23]]}}}